MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Dollar
Positive Cash Flow Breakdown
Accounts payable and accrued exp...
Interest receivable
Stock-based compensation expense
Negative Cash Flow Breakdown
Net loss
Prepaid expenses and other curre...
Payments on short-term notes pay...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-2,528,707
-2,201,243
-2,286,870
-3,066,589
Amortization of debt discount and closing costs
-
-
0
0
Stock-based compensation expense
17,583
17,386
611,839
6,040
Stock-based compensation recapture expense
-
-
0
0
Common stock issued for services
0
5,000
126,140
-
Other receivables
-
-
53,082
-
Income receivables
-
-53,082
-
-
Interest receivable
-53,082
-
-
-
Prepaid expenses and other current assets
245,759
-232,398
313,178
1,135,815
Accounts payable and accrued expenses
570,123
-307,267
-920,261
1,211,849
Net cash used in operating activities
-2,186,760
-2,200,644
-2,835,412
-2,984,515
Proceeds from sale of short-term investments
0
4,000,000
-
-
Borrowings on short-term notes payable
-
-
-167,488
394,836
Net cash provided by investing activities
0
4,000,000
-
-
Payments on short-term notes payable
56,134
171,214
0
3,000,000
Net proceeds from issuance of preferred stock and warrants
-
-
0
15,019,700
Net proceeds from issuance of common stock
0
79,210
-1,140
0
Net cash (used) provided by financing activities
-56,134
-92,004
-168,628
12,414,536
Net increase (decrease) in cash and cash equivalents
-
-
-3,004,040
9,430,021
Net changes in cash and cash equivalents
-2,242,894
1,707,352
-
-
Cash and cash equivalents at beginning of period
6,107,078
4,399,726
11,403,766
864,840
Cash and cash equivalents at end of period
3,864,184
6,107,078
8,399,726
11,403,766
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net changes in cash
and cash...
-$2,242,894
Accounts payable and
accrued expenses
$570,123
(744.61%↑ Y/Y)
Interest receivable
-$53,082
Stock-based compensation
expense
$17,583
(-28.19%↓ Y/Y)
Net cash used in
operating activities
-$2,186,760
(36.18%↑ Y/Y)
Net cash (used)
provided by financing...
-$56,134
(-101.24%↓ Y/Y)
Canceled cashflow
$640,788
Net loss
-$2,528,707
(43.67%↑ Y/Y)
Payments on short-term
notes payable
$56,134
(-82.91%↓ Y/Y)
Prepaid expenses and
other current assets
$245,759
(155.64%↑ Y/Y)
Buy us a coffee
ORAGENICS INC (OGEN)
ORAGENICS INC (OGEN)